PLANNED MAINTENANCE

There will be scheduled maintenance work beginning on Wednesday 26th February 2020 from 11:00 AM through to 12.00 PM (GMT).

During this time, you may not be able to log into ChemSpider. We apologise for any inconvenience this might cause and thank you for your patience.


ChemSpider 2D Image | capivasertib | C21H25ClN6O2

capivasertib

  • Molecular FormulaC21H25ClN6O2
  • Average mass428.915 Da
  • Monoisotopic mass428.172760 Da
  • ChemSpider ID28189073
  • defined stereocentres - 1 of 1 defined stereocentres


More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

10668
1143532-39-1 [RN]
4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(1H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide [ACD/IUPAC Name]
4-Amino-N-[(1S)-1-(4-chlorophényl)-3-hydroxypropyl]-1-(1H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-pipéridinecarboxamide [French] [ACD/IUPAC Name]
4-Amino-N-[(1S)-1-(4-chlorphenyl)-3-hydroxypropyl]-1-(1H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidincarboxamid [German] [ACD/IUPAC Name]
4-Piperidinecarboxamide, 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- [ACD/Index Name]
AZD-5363
capivasertib [INN]
capivasertib [Spanish] [INN]
capivasertib [French] [INN]
More...
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Bio Activity:

      Akt MedChem Express HY-15431
      AZD5363, a novel pyrrolopyrimidine-derived compound, inhibits all AKT isoforms (IC50 <10 nM).; IC50 Value: <10 nM(Akt1/2/3); Target: pan-Akt; AZD5363 has potential to treat a range of solid and hematologic tumors as monotherapy or a combinatorial agent, and has potential for personalized medicine based on the genetic status of PIK3CA, PTEN, and RAS.; in vitro: AZD5363, a novel pyrrolopyrimidine-derived compound, inhibited all AKT isoforms with a potency of 10 nmol/L or less and inhibited phosphorylation of AKT substrates in cells with a potency of approximately 0.3 to 0.8 ?mol/L. MedChem Express HY-15431
      PI3K/Akt/mTOR MedChem Express HY-15431
      PI3K/Akt/mTOR; MedChem Express HY-15431

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

Density: 1.4±0.1 g/cm3
Boiling Point:
Vapour Pressure:
Enthalpy of Vaporization:
Flash Point:
Index of Refraction: 1.670
Molar Refractivity: 116.0±0.3 cm3
#H bond acceptors: 8
#H bond donors: 5
#Freely Rotating Bonds: 6
#Rule of 5 Violations: 1
ACD/LogP: 1.04
ACD/LogD (pH 5.5): -0.58
ACD/BCF (pH 5.5): 1.00
ACD/KOC (pH 5.5): 1.55
ACD/LogD (pH 7.4): 1.18
ACD/BCF (pH 7.4): 4.27
ACD/KOC (pH 7.4): 89.56
Polar Surface Area: 120 Å2
Polarizability: 46.0±0.5 10-24cm3
Surface Tension: 71.7±3.0 dyne/cm
Molar Volume: 310.6±3.0 cm3

Click to predict properties on the Chemicalize site






Advertisement